openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Discover

Markets

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

zemprocitinib — news, coverage & facts — IJR

|NewsJournalsTopiczemprocitinib

Topic

zemprocitinib

0 members

Comments

Ask this entity anything:

Free account · your comment posts right after signup

Facts from Wikidata (CC0).

Zemprocitinib is an investigational new drug that is be evaluated by Lynk Pharmaceuticals for the treatment of ankylosing spondylitis and rheumatoid arthritis. It is an janus kinase 1 (JAK1) inhibitor.

Overview

Zemprocitinib is an investigational new drug that is be evaluated by Lynk Pharmaceuticals for the treatment of ankylosing spondylitis and rheumatoid arthritis. It is an janus kinase 1 (JAK1) inhibitor.

From Wikipedia (CC BY-SA 4.0).

zemprocitinib across IJR

Ask IJR about zemprocitinib Create in Studio Build a game Watch videos